Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
270.95
+1.58 (0.59%)
Mar 28, 2024, 4:00 PM EDT - Market closed
CRL Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4,129 | 3,976 | 3,540 | 2,924 | 2,621 | 2,266 | 1,858 | 1,681 | 1,363 | 1,298 | Upgrade
|
Revenue Growth (YoY) | 3.86% | 12.31% | 21.08% | 11.55% | 15.67% | 21.99% | 10.48% | 23.34% | 5.06% | 11.34% | Upgrade
|
Cost of Revenue | 2,627 | 2,513 | 2,206 | 1,850 | 1,663 | 1,426 | 1,157 | 1,037 | 832.21 | 825 | Upgrade
|
Gross Profit | 1,503 | 1,463 | 1,335 | 1,074 | 958.31 | 840.07 | 700.92 | 643.96 | 531.09 | 472.66 | Upgrade
|
Selling, General & Admin | 747.86 | 665.1 | 619.92 | 528.94 | 517.62 | 443.85 | 371.27 | 364.71 | 300.41 | 269.03 | Upgrade
|
Other Operating Expenses | 137.44 | 146.58 | 124.86 | 111.88 | 89.54 | 64.83 | 41.37 | 41.7 | 24.23 | 25.96 | Upgrade
|
Operating Expenses | 885.3 | 811.68 | 744.78 | 640.81 | 607.16 | 508.68 | 412.64 | 406.41 | 324.64 | 294.99 | Upgrade
|
Operating Income | 617.26 | 650.98 | 589.86 | 432.73 | 351.15 | 331.38 | 288.28 | 237.55 | 206.45 | 177.67 | Upgrade
|
Interest Expense / Income | 136.71 | 59.29 | 73.91 | 86.43 | 60.88 | 63.77 | 29.78 | 27.71 | 15.07 | 11.95 | Upgrade
|
Other Expense / Income | -94.99 | -24.92 | 43.1 | -99.82 | -11.77 | -13.23 | -36.22 | -11.76 | -1.33 | -8.65 | Upgrade
|
Pretax Income | 575.54 | 616.61 | 472.86 | 446.11 | 302.04 | 280.84 | 294.72 | 221.6 | 192.7 | 174.37 | Upgrade
|
Income Tax | 100.91 | 130.38 | 81.87 | 81.81 | 50.02 | 54.46 | 171.37 | 66.84 | 43.39 | 47.67 | Upgrade
|
Net Income | 474.62 | 486.23 | 390.98 | 364.3 | 252.02 | 226.37 | 123.36 | 154.77 | 149.31 | 126.7 | Upgrade
|
Net Income Growth | -2.39% | 24.36% | 7.32% | 44.55% | 11.33% | 83.51% | -20.30% | 3.65% | 17.85% | 23.21% | Upgrade
|
Shares Outstanding (Basic) | 51 | 51 | 50 | 50 | 49 | 48 | 47 | 47 | 47 | 47 | Upgrade
|
Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 50 | 49 | 49 | 48 | - | - | Upgrade
|
Shares Change | 0.29% | -0.24% | 1.61% | 1.85% | 1.38% | 0.93% | 1.26% | 2.86% | -0.64% | -2.49% | Upgrade
|
EPS (Basic) | 9.27 | 9.57 | 7.77 | 7.35 | 5.17 | 4.72 | 2.60 | 3.29 | 3.21 | 2.72 | Upgrade
|
EPS (Diluted) | 9.22 | 9.48 | 7.60 | 7.20 | 5.07 | 4.62 | 2.54 | 3.23 | 3.13 | 2.66 | Upgrade
|
EPS Growth | -2.74% | 24.74% | 5.56% | 42.01% | 9.74% | 81.89% | -21.36% | 3.19% | 17.67% | 25.47% | Upgrade
|
Free Cash Flow | 365.37 | 294.91 | 532.03 | 380.02 | 340.42 | 301.09 | 235.64 | 261.61 | 243.58 | 195.21 | Upgrade
|
Free Cash Flow Per Share | 7.13 | 5.80 | 10.58 | 7.67 | 6.99 | 6.28 | 4.96 | 5.57 | 5.22 | 4.16 | Upgrade
|
Gross Margin | 36.39% | 36.79% | 37.70% | 36.72% | 36.56% | 37.07% | 37.73% | 38.30% | 38.96% | 36.42% | Upgrade
|
Operating Margin | 14.95% | 16.37% | 16.66% | 14.80% | 13.40% | 14.62% | 15.52% | 14.13% | 15.14% | 13.69% | Upgrade
|
Profit Margin | 11.49% | 12.23% | 11.04% | 12.46% | 9.61% | 9.99% | 6.64% | 9.20% | 10.95% | 9.76% | Upgrade
|
Free Cash Flow Margin | 8.85% | 7.42% | 15.03% | 13.00% | 12.99% | 13.29% | 12.69% | 15.56% | 17.87% | 15.04% | Upgrade
|
Effective Tax Rate | 17.53% | 21.14% | 17.31% | 18.34% | 16.56% | 19.39% | 58.15% | 30.16% | 22.52% | 27.34% | Upgrade
|
EBITDA | 1,026 | 979.77 | 812.31 | 767.47 | 561.02 | 506.39 | 455.66 | 375.97 | 302.66 | 282.76 | Upgrade
|
EBITDA Margin | 24.86% | 24.64% | 22.95% | 26.25% | 21.40% | 22.35% | 24.53% | 22.36% | 22.20% | 21.79% | Upgrade
|
Depreciation & Amortization | 314.12 | 303.87 | 265.54 | 234.92 | 198.1 | 161.78 | 131.16 | 126.66 | 94.88 | 96.45 | Upgrade
|
EBIT | 712.25 | 675.9 | 546.77 | 532.55 | 362.92 | 344.61 | 324.5 | 249.31 | 207.78 | 186.32 | Upgrade
|
EBIT Margin | 17.25% | 17.00% | 15.44% | 18.21% | 13.85% | 15.21% | 17.47% | 14.83% | 15.24% | 14.36% | Upgrade
|